Pygo2 as a novel biomarker in gastric cancer for monitoring drug resistance by upregulating MDR1

Chemotherapy is the main therapy for gastric cancer (GC) both before and after surgery, but the emergence of multidrug resistance (MDR) often leads to disease progression and recurrence. P-glycoprotein, encoded by MDR1, is a well-known multidrug efflux transporter involved in drug resistance develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dongdong, Liu, Yu, Wu, Qiuwan, Zheng, Yahong, Kaweme, Natasha Mupeta, Zhang, Zhiming, Cai, Mingquan, Dong, Youhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040896/
https://www.ncbi.nlm.nih.gov/pubmed/33854595
http://dx.doi.org/10.7150/jca.53356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040896/
https://www.ncbi.nlm.nih.gov/pubmed/33854595
http://dx.doi.org/10.7150/jca.53356

Ejemplares similares